We use cookies for a better user experience. Read our Privacy Policy

I Agree

Microarray Scanners Market

Microarray Scanners Market (Product Type: Fluorescence Microarray Scanners, Charge-coupled Devices Microarray Scanners, Colorimetric Microarray Scanners, and Others; Application: Gene Expression, Drug Discovery, and Others; and End User: Hospitals, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Antigen Microarrays Help Detect Antibodies Against SARS-CoV-2

SARS-CoV-2 is a betacoronavirus, which has led to the worldwide spread of the novel infection. Such trends have accelerated research and development (R&D) in the healthcare sector, including the microarray scanners market. GeneCopoeia - the largest provider of expression-ready clones is publicizing its OmicsArray™ SARS-CoV-2 coronavirus Antigen Microarray, owing to its capability of multiplexing, high throughput, and high sensitivity.

Companies in the microarray scanners market are increasing their focus in gene expression and drug discovery to address the novel coronavirus infection. They are increasing the availability of antigen microarrays that help detect antibodies against SARS-CoV-2 and other pathogens. Protein microarrays are also being preferred for powerful detection of antibodies associated with virus infections, including SARS-CoV-2, SARS-CoV-1, and influenza, among others. Viral proteins are chosen based on a thorough review of peer-reviewed publications.

microarray scanners market infographic

Request a sample to get extensive insights into the Microarray Scanners Market

High-density Peptide Arrays Hold Potential in Discovery of Host-pathogen Interactions

Emerging infectious diseases with little known mechanisms of infection and pathogenicity represent a big challenge for stakeholders in the life sciences industry, research, and clinics. In order to overcome this challenge, companies in the microarray scanners market are providing dedicated glycan arrays to enhance research activities and define precise mechanisms of virus and bacterial infection. Innopsys - a provider of cutting-edge instruments and software for research & diagnostics is gaining recognition for its glycan arrays and high density peptide arrays that are precious tools for understanding immune response, validating vaccines, and defining immunogenic epitomes.

The high-density peptide arrays hold promising potential in the discovery of host-pathogen interactions, pathogen epitopes, and patient immune responses that are essential for the development of new and preventive therapeutic approaches such as for drugs and vaccines.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Near-infrared Fluorescence Useful in Protein Biomarkers Analysis of SARS-CoV-2

The microarray scanners market is predicted to surpass ~27,000 units by the end of 2030. Companies in the microarray scanners market are entering into strategic partnerships to increase the availability of high technology solutions pertaining to innovative microarray platforms for viral infections screening and protein biomarkers analysis. This is being achieved with the help of near-infrared fluorescence, which explains why fluorescence microarray scanners are estimated to dominate the highest revenue among all product types in the market and during the assessment period.

The R&D innovations in fluorescence microarray scanners holds promising potential in the protein biomarkers analysis with respect to Zika, Dengue, and SARS-CoV-2, among others. Proprietary gold-coated slides based on nanotechnology are being used in scanners. This technology deploys superior sensitivity and precision for the detection of sera antibodies developed by infected patients.

CCD V/S CMOS Imaging Sensors: Which is Better?

The microarray scanners market is expected to reach 1.5 Bn by 2030. However, CMOS (Complementary Metal-Oxide Semiconductor) imaging sensors are emerging as an alternative to CCD (Charge Coupled Device) image sensors, as CCD sensors consume increased power as compared to CMOS sensors. As such, CCD sensors help create high quality and low noise images, whereas CMOS sensors are usually more susceptible to noise.

On the other hand, CMOS sensors are much less expensive to manufacture than CCD sensors and are rapidly improving performance. Such trends are likely to affect revenue generation in the microarray scanners market. Hence, companies in the market should fuel their manufacturing by increasing R&D in CMOS imaging sensors. As such, it has been found that CCD sensors are still required for certain demanding applications. Thus, device manufacturers should weigh the pros and cons of CCD image sensors to stay relevant to ongoing trends in the market.

microarray scanners market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Microarray Scanners Market

Analysts’ Viewpoint

In the light of the ongoing COVID-19 outbreak, companies are increasing the availability of glycan arrays and high-density peptide arrays that play a crucial role in understanding immune response, validating vaccines, and defining immunogenic epitomes. However, CMOS imaging sensors are emerging as an alternative to CCD imaging sensors, owing to their cost efficient and low power consumption advantages. Hence, stakeholders in the microarray scanners market should consider weighing the pros and cons of CCD & CMOS, whilst identifying how CCD is being used in demanding applications with the help of microarray scanners. Companies in the microarray scanners market should enter into strategic partnerships to advance in near-infrared fluorescence, which helps in detection of sera antibodies developed by infected patients.

Microarray Scanners Market: Overview

  • This report analyzes the current and future prospects of the global microarray scanners market. Rise in need of early cancer detection & diagnosis and increase in the population with infectious diseases such as COVID-19 are the key factors projected to fuel the growth of the global microarray scanners market during the forecast period.
  • The report provides an elaborate executive summary, which comprises a snapshot of the various segments of the global microarray scanners market. The report also provides information and data analysis of the global microarray scanners market about segments based on product type, application, end user, and region.
  • The overview section of the report provides detailed qualitative analysis of drivers and restraints impacting the global microarray scanners market along with opportunities in the global market
  • Additionally, the global microarray scanners market report includes company profiles and competitive matrix, which provide data about their businesses, product portfolios, and competitive landscape in the global microarray scanners market
  • The report includes data analysis on the microarray scanners market attractiveness by region and segments
  • The last section of the report provides quantitative and qualitative analysis on market share of key players operating in the global microarray scanners market. It elaborates on the key competitive strategies adopted by the major industry players, thereby presenting a thorough understanding of the competitive scenario in the global microarray scanners market.

Microarray Scanners Market: Key Segments

  • In terms of product type, the global microarray scanners market has been classified into fluorescence microarray scanners, charge-coupled devices microarray scanners, colorimetric microarray scanners, and others
  • The fluorescence microarray scanners segment held a major share of the global microarray scanners market in 2020
  • Based on application, the global microarray scanners market has been divided into gene expression, drug discovery, and others. The gene expression segment is projected to dominate the global microarray scanners market during the forecast period.
  • In terms of end user, the global microarray scanners market has been categorized into hospitals, diagnostic laboratories, pharmaceutical & biotechnology companies, and academic & research institutes. The diagnostic laboratories segment is anticipated to lead the global microarray scanners market during the forecast period.
  • The market size and forecast for each of these segments have been provided from 2018 to 2030. The CAGR of respective segment has also been provided for the forecast period from 2020 to 2030, considering 2019 as the base year.

Microarray Scanners Market: Regional Outlook

  • In terms of region, the global microarray scanners market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa)
  • The report provides market size and forecast for each region and country/sub-region from 2018 to 2030. Compound annual growth rates (CAGR) of each of these regions and countries have also been provided for the forecast period from 2020 to 2030, considering 2019 as the base year. The microarray scanners market study also covers the competitive scenario in these regions.

Companies Mentioned in Report

  • Key players in the global microarray scanners market have been profiled based on key aspects such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
  • Major companies profiled in the global microarray scanners market report are
    • Thermo Fisher Scientific
    • Agilent Technologies
    • Illumina, Inc.
    • PerkinElmer, Inc.
    • F. Hoffmann-La Roche Ltd.
    • GE Healthcare (General Electric Company)
    • Molecular Devices, LLC. (Danaher Corporation)
    • Innopsys Inc.
    • Berthold Technologies GmbH & Co. KG.

Microarray Scanners Market – Segmentation

Product Type
  • Fluorescence Microarray Scanners
  • Charge-coupled Devices Microarray Scanners
  • Colorimetric Microarray Scanners
  • Others
Application
  • Gene Expression
  • Drug Discovery
  • Others
End User
  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Microarray Scanners Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of microarray scanners market?

The global microarray scanners market was worth US$ 700 Mn and is projected to reach a value of US$ 1.5 Bn by the end of 2030

What is the anticipated CAGR of the microarray scanners market in the forecast period?

Microarray scanners market is anticipated to grow at a CAGR of 7% during the forecast period

Which region is expected to project the highest market share in microarray scanners market?

North America accounted for a major share of the global microarray scanners market

What are the key driving factors for growth of microarray scanners market?

Microarray scanners market is driven by rise in demand for preventive healthcare, well-established healthcare facilities, rapidly increasing geriatric population, and high per capita healthcare expenditure are anticipated to drive the global market from 2020 to 2030

Who are the key players in the global microarray scanners market?

Key players in the global microarray scanners market include Thermo Fisher Scientific, Agilent Technologies, Illumina, Inc., PerkinElmer Inc., F. Hoffmann-La Roche Ltd., GE Healthcare (General Electric Company), Molecular Devices, LLC (Danaher Corporation), Innopsys Inc., and Berthold Technologies GmbH & Co. KG

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Microarray Scanners Market

4. Market Overview

    4.1. Introduction

        4.1.1. Market Introduction

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Microarray Scanners Market Analysis and Forecast, 2018–2030

        4.4.1. Market Revenue Projections (US$ Mn)

        4.4.2. Market Volume/Unit Shipments Projections

5. Key Insights

    5.1. Key Mergers & Acquisitions

    5.2. Technological Advancements

    5.3. User Base for OncoScanand CytoSNPin EU5 Countries

    5.4. Number of labs with the instruments such as iScan, NextSeq550, GeneChip Scanner 3000 7G, GeneChip Scanner 3000 Dx2 that can run CytoSNP& OncoScan

    5.5. Bioinformatics platforms that are being used with these instruments

    5.6. % of these instruments are used for clinical decision making

    5.7. Effort (time/cost) required to operationalize / validate these instruments

    5.8. Workflow details – batch size, TAT, cost/test

    5.9. Covid-19 Impact Analysis

6. Global Microarray Scanners Market Analysis and Forecast, by Product Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product Type , 2018–2030

        6.3.1. Fluorescence Microarray Scanners

        6.3.2. Charge-coupled Devices Microarray Scanners

        6.3.3. Colorimetric Microarray Scanners

        6.3.4. Others

    6.4. Market Attractiveness Analysis, by Product Type

7. Global Microarray Scanners Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Application, 2018–2030

        7.3.1. Gene Expression

        7.3.2. Drug Discovery

        7.3.3. Others

    7.4. Market Attractiveness Analysis, by Application

8. Global Microarray Scanners Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by End-user, 2018–2030

        8.3.1. Hospitals

        8.3.2. Diagnostic Laboratories

        8.3.3. Pharmaceutical & Biotechnology Companies

        8.3.4. Academic & Research Institutes

    8.4. Market Attractiveness Analysis, by End-user

9. Global Microarray Scanners Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Country/Region

10. North America Microarray Scanners Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product Type, 2018–2030

        10.2.1. Fluorescence Microarray Scanners

        10.2.2. Charge-coupled Devices Microarray Scanners

        10.2.3. Colorimetric Microarray Scanners

        10.2.4. Others

    10.3. Market Value Forecast, by Application, 2018–2030

        10.3.1. Gene Expression

        10.3.2. Drug Discovery

        10.3.3. Others

    10.4. Market Value Forecast, by End-user, 2018–2030

        10.4.1. Hospitals

        10.4.2. Diagnostic Laboratories

        10.4.3. Pharmaceutical & Biotechnology Companies

        10.4.4. Academic & Research Institutes

    10.5. Market Value Forecast, by Country, 2018–2030

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Product Type

        10.6.2. By Application

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Microarray Scanners Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product Type, 2018–2030

        11.2.1. Fluorescence Microarray Scanners

        11.2.2. Charge-coupled Devices Microarray Scanners

        11.2.3. Colorimetric Microarray Scanners

        11.2.4. Others

    11.3. Market Value Forecast, by Application, 2018–2030

        11.3.1. Gene Expression

        11.3.2. Drug Discovery

        11.3.3. Others

    11.4. Market Value Forecast, by End-user, 2018–2030

        11.4.1. Hospitals

        11.4.2. Diagnostic Laboratories

        11.4.3. Pharmaceutical & Biotechnology Companies

        11.4.4. Academic & Research Institutes

    11.5. Market Value Forecast, by Country/Sub-region, 2018–2030

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Italy

        11.5.5. Spain

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Product Type

        11.6.2. By Application

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Microarray Scanners Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product Type, 2018–2030

        12.2.1. Fluorescence Microarray Scanners

        12.2.2. Charge-coupled Devices Microarray Scanners

        12.2.3. Colorimetric Microarray Scanners

        12.2.4. Others

    12.3. Market Value Forecast, by Application, 2018–2030

        12.3.1. Gene Expression

        12.3.2. Drug Discovery

        12.3.3. Others

    12.4. Market Value Forecast, by End-user, 2018–2030

        12.4.1. Hospitals

        12.4.2. Diagnostic Laboratories

        12.4.3. Pharmaceutical & Biotechnology Companies

        12.4.4. Academic & Research Institutes

    12.5. Market Value Forecast, by Country/Sub-region, 2018–2030

        12.5.1. Japan

        12.5.2. China

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Product Type

        12.6.2. By Application

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Microarray Scanners Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product Type, 2018–2030

        13.2.1. Fluorescence Microarray Scanners

        13.2.2. Charge-coupled Devices Microarray Scanners

        13.2.3. Colorimetric Microarray Scanners

        13.2.4. Others

    13.3. Market Value Forecast, by Application, 2018–2030

        13.3.1. Gene Expression

        13.3.2. Drug Discovery

        13.3.3. Others

    13.4. Market Value Forecast, by End-user, 2018–2030

        13.4.1. Hospitals

        13.4.2. Diagnostic Laboratories

        13.4.3. Pharmaceutical & Biotechnology Companies

        13.4.4. Academic & Research Institutes

    13.5. Market Value Forecast, by Country/Sub-region, 2018–2030

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Product Type

        13.6.2. By Application

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Microarray Scanners Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Product Type, 2018–2030

        14.2.1. Fluorescence Microarray Scanners

        14.2.2. Charge-coupled Devices Microarray Scanners

        14.2.3. Colorimetric Microarray Scanners

        14.2.4. Others

    14.3. Market Value Forecast, by Application, 2018–2030

        14.3.1. Gene Expression

        14.3.2. Drug Discovery

        14.3.3. Others

    14.4. Market Value Forecast, by End-user, 2018–2030

        14.4.1. Hospitals

        14.4.2. Diagnostic Laboratories

        14.4.3. Pharmaceutical & Biotechnology Companies

        14.4.4. Academic & Research Institutes

    14.5. Market Value Forecast, by Country/Sub-region, 2018–2030

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Product Type

        14.6.2. By Application

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by tier and size of companies)

    15.2. Market Share Analysis by Company (2020)

    15.3. Company Profiles

        15.3.1. Thermo Fisher Scientific

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Growth Strategies

            15.3.1.3. SWOT Analysis

        15.3.2. Agilent Technologies

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Growth Strategies

            15.3.2.3. SWOT Analysis

        15.3.3. Illumina, Inc.

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Growth Strategies

            15.3.3.3. SWOT Analysis

        15.3.4. PerkinElmer, Inc.

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Growth Strategies

            15.3.4.3. SWOT Analysis

        15.3.5. F. Hoffmann-La Roche Ltd.

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Growth Strategies

            15.3.5.3. SWOT Analysis

        15.3.6. GE Healthcare (General Electric Company)

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Growth Strategies

            15.3.6.3. SWOT Analysis

        15.3.7. Molecular Devices, LLC (Danaher Corporation)

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Growth Strategies

            15.3.7.3. SWOT Analysis

        15.3.8. Innopsys, Inc.

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Growth Strategies

            15.3.8.3. SWOT Analysis

        15.3.9. Berthold Technologies GmbH & Co. KG

            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.9.2. Growth Strategies

            15.3.9.3. SWOT Analysis

List of Tables

Table 1.1: List of Labs Using Microarray Instruments, by Country

Table 1.2: List of Labs Using Microarray Instruments, by Country

Table 02: User Base for OncoScan and CytoSNP in EU5 Countries

Table 03: Number of labs with the Microarray instruments in EU5 Countries

Table 04: Effort (time/cost) required to operationalize/validate Microarray instruments (Germany)

Table 05: Effort (time/cost) required to operationalize/validate Microarray instruments (U.K.)

Table 06: Effort (time/cost) required to operationalize/validate Microarray instruments (France)

Table 07: Effort (time/cost) required to operationalize/validate Microarray instruments (Italy)

Table 08: Effort (time/cost) required to operationalize/validate Microarray instruments (Spain)

Table 09: Effort (time/cost) required to operationalize/validate Microarray instruments

Table 10: Global Microarray Scanners Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

Table 11: Global Microarray Scanners Market Volume (Units) Forecast, by Product Type, 2018–2030

Table 12: Global Microarray Scanners Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 13: Global Microarray Scanners Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 14: Global Microarray Scanners Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 15: North America Microarray Scanners Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 16: North America Microarray Scanners Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

Table 17: North America Microarray Scanners Market Volume (Units) Forecast, by Product Type, 2018–2030

Table 18: North America Microarray Scanners Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 19: North America Microarray Scanners Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 20: Europe Microarray Scanners Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 21: Europe Microarray Scanners Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

Table 22: Europe Microarray Scanners Market Volume (Units) Forecast, by Product Type, 2018–2030

Table 23: Europe Microarray Scanners Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 24: Europe Microarray Scanners Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 25: Asia Pacific Microarray Scanners Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 26: Asia Pacific Microarray Scanners Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

Table 27: Asia Pacific Microarray Scanners Market Volume (Units) Forecast, by Product Type, 2018–2030

Table 28: Asia Pacific Microarray Scanners Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 29: Asia Pacific Microarray Scanners Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 30: Latin America Microarray Scanners Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 31: Latin America Microarray Scanners Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

Table 32: Latin America Microarray Scanners Market Volume (Units) Forecast, by Product Type, 2018–2030

Table 33: Latin America Microarray Scanners Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 34: Latin America Microarray Scanners Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 35: Middle East & Africa Microarray Scanners Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 36: Middle East & Africa Microarray Scanners Market Value (US$ Mn) Forecast, by Product Type, 2018–2030

Table 37: Middle East & Africa Microarray Scanners Market Volume (Units) Forecast, by Product Type, 2018–2030

Table 38: Middle East & Africa Microarray Scanners Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 39: Middle East & Africa Microarray Scanners Market Value (US$ Mn) Forecast, by End-user, 2018–2030

List of Figures

Figure 01: Global Microarray Scanners Market Value (US$ Mn) Forecast, 2018–2030

Figure 02: Global Microarray Scanners Market Value Share, by Product Type, 2019

Figure 03: Global Microarray Scanners Market Value Share, by End-user, 2019

Figure 04: Global Microarray Scanners Market Value Share, by Application, 2019

Figure 05: Global Microarray Scanners Market Value Share, by Region, 2019

Figure 06: Global Microarray Scanners Market Value Share Analysis, by Product Type, 2019 and 2030

Figure 07: Global Microarray Scanners Market Attractiveness Analysis, by Product Type, 2020–2030

Figure 08: Global Microarray Scanners Market Revenue (US$ Mn), by Fluorescence Microarray Scanners, 2018–2030

Figure 09: Global Microarray Scanners Market Revenue (US$ Mn), by Charge-coupled Devices Microarray Scanners, 2018–2030

Figure 10: Global Microarray Scanners Market Revenue (US$ Mn), by Colorimetric Microarray Scanners, 2018–2030

Figure 11: Global Microarray Scanners Market Revenue (US$ Mn), by Others, 2018–2030

Figure 12: Global Microarray Scanners Market Value Share Analysis, by Application, 2019 and 2030

Figure 13: Global Microarray Scanners Market Attractiveness Analysis, by Application, 2020–2030

Figure 14: Global Microarray Scanners Market Revenue (US$ Mn), by Gene Expression, 2018–2030

Figure 15: Global Microarray Scanners Market Revenue (US$ Mn), by Drug Discovery, 2018–2030

Figure 16: Global Microarray Scanners Market Revenue (US$ Mn), by Others, 2018–2030

Figure 17: Global Microarray Scanners Market Value Share Analysis, by End-user, 2019 and 2030

Figure 18: Global Microarray Scanners Market Attractiveness Analysis, by End-user, 2020–2030

Figure 19: Global Microarray Scanners Market Revenue (US$ Mn), by Hospitals, 2018–2030

Figure 20: Global Microarray Scanners Market Revenue (US$ Mn), by Diagnostic Laboratories, 2018–2030

Figure 21: Global Microarray Scanners Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2018–2030

Figure 22: Global Microarray Scanners Market Revenue (US$ Mn), by Academic & Research Institutes, 2018–2030

Figure 23: Global Microarray Scanners Market Value Share Analysis, by Region, 2019 and 2030

Figure 24: Global Microarray Scanners Market Attractiveness Analysis, by Region, 2020–2030

Figure 25: North America Microarray Scanners Market Value (US$ Mn) Forecast, 2018–2030

Figure 26: North America Microarray Scanners Market Value Share Analysis, by Country, 2019 and 2030

Figure 27: North America Microarray Scanners Market Attractiveness Analysis, by Country, 2020–2030

Figure 28: North America Microarray Scanners Market Value Share Analysis, by Product Type, 2019 and 2030

Figure 29: North America Microarray Scanners Market Attractiveness Analysis, by Product Type, 2020–2030

Figure 30: North America Microarray Scanners Market Value Share Analysis, by Application, 2019 and 2030

Figure 31: North America Microarray Scanners Market Attractiveness Analysis, by Application, 2020–2030

Figure 32: North America Microarray Scanners Market Value Share Analysis, by End-user, 2019 and 2030

Figure 33: North America Microarray Scanners Market Attractiveness Analysis, by End-user, 2020–2030

Figure 34: Europe Microarray Scanners Market Value (US$ Mn) Forecast, 2018–2030

Figure 35: Europe Microarray Scanners Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 36: Europe Microarray Scanners Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 37: Europe Microarray Scanners Market Value Share Analysis, by Product Type, 2019 and 2030

Figure 38: Europe Microarray Scanners Market Attractiveness Analysis, by Product Type, 2020–2030

Figure 39: Europe Microarray Scanners Market Value Share Analysis, by Application, 2019 and 2030

Figure 40: Europe Microarray Scanners Market Attractiveness Analysis, by Application, 2020–2030

Figure 41: Europe Microarray Scanners Market Value Share Analysis, by End-user, 2019 and 2030

Figure 42: Europe Microarray Scanners Market Attractiveness Analysis, by End-user, 2020–2030

Figure 43: Asia Pacific Microarray Scanners Market Value (US$ Mn) Forecast, 2018–2030

Figure 44: Asia Pacific Microarray Scanners Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 45: Asia Pacific Microarray Scanners Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 46: Asia Pacific Microarray Scanners Market Value Share Analysis, by Product Type, 2019 and 2030

Figure 47: Asia Pacific Microarray Scanners Market Attractiveness Analysis, by Product Type, 2020–2030

Figure 48: Asia Pacific Microarray Scanners Market Value Share Analysis, by Application, 2019 and 2030

Figure 49: Asia Pacific Microarray Scanners Market Attractiveness Analysis, by Application, 2020–2030

Figure 50: Asia Pacific Microarray Scanners Market Value Share Analysis, by End-user, 2019 and 2030

Figure 51: Asia Pacific Microarray Scanners Market Attractiveness Analysis, by End-user, 2020–2030

Figure 52: Latin America Microarray Scanners Market Value (US$ Mn) Forecast, 2018–2030

Figure 53: Latin America Microarray Scanners Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 54: Latin America Microarray Scanners Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 55: Latin America Microarray Scanners Market Value Share Analysis, by Product Type, 2019 and 2030

Figure 56: Latin America Microarray Scanners Market Attractiveness Analysis, by Product Type, 2020–2030

Figure 57: Latin America Microarray Scanners Market Value Share Analysis, by Application, 2019 and 2030

Figure 58: Latin America Microarray Scanners Market Attractiveness Analysis, by Application, 2020–2030

Figure 59: Latin America Microarray Scanners Market Value Share Analysis, by End-user, 2019 and 2030

Figure 60: Latin America Microarray Scanners Market Attractiveness Analysis, by End-user, 2020–2030

Figure 61: Middle East & Africa Microarray Scanners Market Value (US$ Mn) Forecast, 2018–2030

Figure 62: Middle East & Africa Microarray Scanners Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 63: Middle East & Africa Microarray Scanners Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 64: Middle East & Africa Microarray Scanners Market Value Share Analysis, by Product Type, 2019 and 2030

Figure 65: Middle East & Africa Microarray Scanners Market Attractiveness Analysis, by Product Type, 2020–2030

Figure 66: Middle East & Africa Microarray Scanners Market Value Share Analysis, by Application, 2019 and 2030

Figure 67: Middle East & Africa Microarray Scanners Market Attractiveness Analysis, by Application, 2020–2030

Figure 68: Middle East & Africa Microarray Scanners Market Value Share Analysis, by End-user, 2019 and 2030

Figure 69: Middle East & Africa Microarray Scanners Market Attractiveness Analysis, by End-user, 2020–2030

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

974

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved